Kana Matsushima

Title: Innovations of Kana Matsushima in Recombinant Cell Technology

Introduction

Kana Matsushima is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant cells. Her work focuses on the synthesis of isoprene and terpenes, which are vital compounds in various industrial applications.

Latest Patents

Kana Matsushima holds a patent for a recombinant cell, method for producing recombinant cell, and method for producing isoprene or terpene. This innovative recombinant cell is designed to produce isoprene or terpene by synthesizing isopentenyl diphosphate through a mevalonate pathway (MVA pathway). Notably, the recombinant cell lacks the ability to synthesize isopentenyl diphosphate through an endogenous non-mevalonate pathway (MEP pathway). The cell incorporates an isoprene synthase gene or a terpene synthase gene as a foreign gene, enabling it to produce isoprene or terpene with varying carbon atom counts, specifically 10, 15, 20, 30, or 40 carbon atoms. The mevalonate pathway utilized is preferably an exogenous mevalonate pathway.

Career Highlights

Kana Matsushima is currently employed at Sekisui Chemical Co., Ltd., where she continues to advance her research in biotechnology. Her innovative approach to recombinant cell technology has positioned her as a key figure in her field.

Collaborations

Kana has collaborated with notable colleagues, including Masahiro Furutani and Kazufumi Kawabata. These collaborations have further enhanced her research and development efforts in biotechnology.

Conclusion

Kana Matsushima's contributions to recombinant cell technology exemplify her innovative spirit and dedication to advancing the field of biotechnology. Her work not only highlights her expertise but also the potential applications of her inventions in various industries.